Nano Archive

Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice

Banciu, Manuela and Metselaar, Josbert M. and Schiffelers, Raymond M. and Storm, Gert (2008) Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 111 (1-2). pp. 101-110.

Full text is not hosted in this archive but may be available via the Official URL, or by requesting a copy from the corresponding author.

Official URL:


This study evaluates whether the inhibitory effects of prednisolone phosphate (PLP) encapsulated in long-circulating liposomes (LCL-PLP) on tumor growth and tumor angiogenesis described previously can be generalized to other types of glucocorticoids (GC) encapsulated in LCL (LCL-GC). Four types of synthetic GC, i.e. budesonide disodium phosphate (BLIP), dexamethasone disodium phosphate (DXP), methylprednisolone disodium phosphate (MPLP), and PLP, were selected based on the difference in their potency to activate the human glucocorticoid receptor. The effects of all LCL-GC on the production of angiogenic/inflammatory factors in vivo in the B16.F10 murine melanoma model as well as on the viability and proliferation of tumor cells and endothelial cells in vitro were investigated. Our results show that all four selected LCL-GC formulations inhibit tumor growth, albeit to different degrees. The differences in antitumor activity of LCL-GC correlate with their efficacy to suppress tumor angiogenesis and inflammation. The strongest antitumor effect is achieved by LCL-encapsulated BLIP (LCL-BUP), due to the highest potency of BLIP versus the other three GC types. The in vitro results presented herein suggest that LCL-BUP has strong cytotoxic effects on B16.F10 melanoma cells and the anti-proliferative effects of all LCL-GC towards angiogenic endothelial cells play a role in their antitumor activity. (C) 2008 Elsevier Ltd. All rights reserved.

Item Type:Article
Uncontrolled Keywords:glucocorticoids; liposomes; angiogenesis; inflammation; cancer
Subjects:Biomedical Science > Nanomedicine
ID Code:2697
Deposited By:Farnush Anwar
Deposited On:09 Jan 2009 11:50
Last Modified:22 Jan 2009 15:45

Repository Staff Only: item control page